Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million

Bulletin Express07-23

Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share buyback on 23 July 2026, purchasing 112,300 H-shares on the Hong Kong Stock Exchange at prices between HKD 17.48 and HKD 18.14. The transaction totaled HKD 1.99 million.

Following the repurchase, the company’s issued share capital (excluding treasury shares) declined to 152.84 million shares, down 0.07%. Treasury shares increased to 1.48 million, keeping the total issued share count unchanged at 154.33 million.

The buyback was executed under the mandate approved on 26 May 2026, which authorizes the company to repurchase up to 15.43 million shares. Cumulative repurchases under this mandate now stand at 1.48 million shares, equivalent to 0.96% of the share base at the mandate date.

All repurchased shares are held as treasury stock; none have been cancelled. In line with listing rules, Bao Pharma is subject to a moratorium on issuing new shares or transferring treasury shares until 22 August 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1155446130?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-23 18:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1155446130","market":"hk","top_or_hot":-1,"title":"Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million","media":"Bulletin Express","content":"<p>Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share buyback on 23 July 2026, purchasing 112,300 H-shares on the Hong Kong Stock Exchange at prices between HKD 17.48 and HKD 18.14. The transaction totaled HKD 1.99 million.</p>\n<p>Following the repurchase, the company’s issued share capital (excluding treasury shares) declined to 152.84 million shares, down 0.07%. Treasury shares increased to 1.48 million, keeping the total issued share count unchanged at 154.33 million.</p>\n<p>The buyback was executed under the mandate approved on 26 May 2026, which authorizes the company to repurchase up to 15.43 million shares. Cumulative repurchases under this mandate now stand at 1.48 million shares, equivalent to 0.96% of the share base at the mandate date.</p>\n<p>All repurchased shares are held as treasury stock; none have been cancelled. In line with listing rules, Bao Pharma is subject to a moratorium on issuing new shares or transferring treasury shares until 22 August 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-23 18:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share buyback on 23 July 2026, purchasing 112,300 H-shares on the Hong Kong Stock Exchange at prices between HKD 17.48 and HKD 18.14. The transaction totaled HKD 1.99 million.</p>\n<p>Following the repurchase, the company’s issued share capital (excluding treasury shares) declined to 152.84 million shares, down 0.07%. Treasury shares increased to 1.48 million, keeping the total issued share count unchanged at 154.33 million.</p>\n<p>The buyback was executed under the mandate approved on 26 May 2026, which authorizes the company to repurchase up to 15.43 million shares. Cumulative repurchases under this mandate now stand at 1.48 million shares, equivalent to 0.96% of the share base at the mandate date.</p>\n<p>All repurchased shares are held as treasury stock; none have been cancelled. In line with listing rules, Bao Pharma is subject to a moratorium on issuing new shares or transferring treasury shares until 22 August 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02659","symbol_name":"宝济药业-B","start_time":0,"source_url":"","article_id":"1155446130","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1155446130","pubTimestamp":1784800956,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share buyback on 23 July 2026, purchasing 112,300 H-shares on the Hong Kong Stock Exchange at prices between HKD 17.48 and HKD 18.14....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02659":"宝济药业-B"},"translate_title":"宝医药回购H股11.23万股；美国库存增至148万股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02659":1},"content_text":"Shanghai Bao Pharmaceuticals Co., Ltd. (Bao Pharma) disclosed a share buyback on 23 July 2026, purchasing 112,300 H-shares on the Hong Kong Stock Exchange at prices between HKD 17.48 and HKD 18.14. The transaction totaled HKD 1.99 million.\nFollowing the repurchase, the company’s issued share capital (excluding treasury shares) declined to 152.84 million shares, down 0.07%. Treasury shares increased to 1.48 million, keeping the total issued share count unchanged at 154.33 million.\nThe buyback was executed under the mandate approved on 26 May 2026, which authorizes the company to repurchase up to 15.43 million shares. Cumulative repurchases under this mandate now stand at 1.48 million shares, equivalent to 0.96% of the share base at the mandate date.\nAll repurchased shares are held as treasury stock; none have been cancelled. In line with listing rules, Bao Pharma is subject to a moratorium on issuing new shares or transferring treasury shares until 22 August 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1155446130","isCrawlerRequest":true}